Medical Science

DOWNLOAD PDF | Roadmap to Cannabis Retail: The Three Canadian Models

Original Newsletter(s) this article was published in: Blaneys on Business: January 2019

Co-Author: Alex Fernet Brochu, Articling Student

Dr. Tom Folan of SolaceMD addressed the 2018 CONCIERGE MEDICINE FORUM audience of Physicians and other Healthcare leaders in Atlanta, GA USA about Medical Cannabis … LEARN MORE/READ MORE …

Contributions by: Angela Smith, PhD, Catalyst Life Science Consulting

On October 17, 2018, Canada became the second country in the world, and the first G7 nation, to legalize recreational cannabis.[1] The Cannabis Act[2] and Regulations create a strict legal and regulatory framework for controlling the production, distribution, sale and possession of cannabis across Canada. Under the newly in force Cannabis Act, provinces and territories are responsible for determining how cannabis is distributed and sold within their jurisdictions. This means that each province and territory has been tasked to create its own set of rules governing the “how, where and when” of their individual cannabis distribution and retail system(s).[3] Since the Liberals officially announced on April 20, 2016 that the government would move forward in legalizing cannabis,[4] the provinces and territories have been working toward this goal for varying amounts of time. Post-legalization, each province and territory is at a different level of preparation and readiness.



Categories: Medical Science